Assessing the Impact of Telemedicine on Patient Satisfaction Before and During the COVID-19 Pandemic.

Assessing the Impact of Telemedicine on Patient Satisfaction Before and During the COVID-19 Pandemic.

Publication date: Aug 23, 2025

Objectives: The adoption of telemedicine, which is the delivery of healthcare services through digital platforms, exploded during the COVID-19 pandemic as a means to ensure the continuity of care while minimizing infection risks. While this modality improved access and convenience for many, disparities in adoption have emerged, particularly in rural and underserved populations. This study aims to evaluate the impact of telemedicine on patient satisfaction before and during the pandemic, with a focus on chronic disease management-notably hypertension-and to identify factors influencing the equitable adoption of telehealth. Methods and Procedures: This study used a mixed method approach, combining quantitative survey data and causal loop modeling to analyze patient satisfaction levels and the interplay between telehealth adoption, healthcare access, and demographic disparities. Patient-reported satisfaction data were collected in two time periods-before and during the pandemic. Causal modeling was used to explore systemic relationships between provider support, technology access, patient engagement, and health equity. Results: The findings revealed that telemedicine significantly enhanced healthcare access during the pandemic, with a notable increase in patient satisfaction scores. Patients with chronic conditions, especially those diagnosed with hypertension, reported the improved continuity of care and reduced geographic barriers. However, disparities in telehealth access were more pronounced in non-metropolitan areas and among older adults and minority populations. Causal analysis highlighted key enablers of telehealth success, i. e., provider support, digital literacy, and access to reliable internet and devices. Conclusions: Telemedicine presents a transformative solution for equitable healthcare delivery, especially in chronic disease management. Strategic efforts are needed to address adoption disparities and ensure the sustained and inclusive integration of telehealth after the pandemic.

Open Access PDF

Concepts Keywords
Basel causal model
Exploded chronic conditions
Healthcare COVID-19 pandemic
Relationships patient satisfaction
Rural systems thinking
telemedicine

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH infection
disease MESH chronic disease
disease MESH hypertension
drug DRUGBANK Spinosad
disease IDO quality
drug DRUGBANK Serine
disease MESH causality
disease MESH asthma
pathway KEGG Asthma
drug DRUGBANK C31G
disease IDO country
disease MESH limited English proficiency
disease MESH complications
disease IDO blood
disease MESH cardiovascular diseases
disease MESH lifestyle
disease IDO production
drug DRUGBANK Dextrose unspecified form
disease IDO intervention
disease MESH diabetic ketoacidosis
disease MESH hypoglycemia
disease IDO symptom
disease MESH emergencies
disease MESH panic
drug DRUGBANK Isoxaflutole
disease MESH Privacy
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
disease MESH liver disease

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *